Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 12 Next »


DayDateAM/PMSessionAgenda

Co-Chair
Availability

Room
SundayFebruary 2, 2020AMQ1Not Meeting

AMQ2Not Meeting

AM

Q3

Not Meeting

AMQ4Not Meeting








MondayFebruary 3, 2020AMQ1

Not Meeting



AMQ2Not Meeting

PMQ3Not Meeting

PMQ4Not Meeting








TuesdayFebruary 4, 2020AMQ1

Meeting

  • Review Agenda
  • Reps to other WGs
    • Wed Q2 - O&O - HealthcareProduct: Substance, Substance Definition, BiologicallyDerivedProduct, Supply, Medication, MedicinalProduct, MedicationKnowledge.
    • Wed Q4 - Public Health
    • Thurs Q3 - CDS
    • Fri Q1 - Patient Care - Care Plan report out
  • Assign Roles for Quarters
  • Approval of September 2019 WGM Minutes
  • If we have new attendees, review
    • Overview of Pharmacy material - V2, V3, FHIR
    • Overview of Template work
  • Hot Topics
  • Prep for Joint FHIR meeting

Melva

Jean


AMQ2

Meeting

  • FHIR Trackers
Melva
PMQ3

Meeting

  • Discussion of Medication List with Michelle Miller

Melva

Jean


PMQ4

Meeting

  • FHIR Trackers
Melva







WednesdayFebruary 5, 2020AMQ1Not Meeting

AMQ2

Not Meeting - Rep to O&O



PMQ3Not Meeting

PMQ4

Not Meeting - Rep to Public Health










ThursdayFebruary 6, 2020AMQ1

Meeting

  • Medication List Project

Jean

Melva


AMQ2

Meeting

  • Medication List Project

Jean

Melva


PM

Q3

Meeting - Rep to CDS


Melva
PMQ4

Meeting

  • VA Pharmacy Project - Jay Lyle (material to be provided)
    • Questions:
      • Do these maps make sense? Are there assumptions I’m missing? Are there better approaches?
      • Are there changes coming that might affect our approach?
      • What other stakeholders would be interested in comparing extensions? What’s the best channel for that discussion?
    • Attachments:
      • VAPharmaMaps.xlsx
        • Notes:
          • Columns A-J are VistA metadata. K-R are the proposed design description.

          • There’s a legend for the column headers.

          • The areas of most interest will be the orders in the area (B) column:

            • Inpatient Orders - pending/non-verified

            • Inpatient Orders IV/Clinic Infusions

            • Inpatient Orders Unit Dose/Clinic Medications

            • Outpatient Orders

            • Outpatient Orders - pending

            • Non-VA Medications

      • DD19_20191122_1155_JayLyle_BalancingActExposingLegacyDataInFHIR.pptx
        • I also attach a slide deck for a high-level overview of what’s going on in there, for what it’s worth, which you can read or I can present, or both.

Jean?

Melva









Friday

February 7, 2020

AMQ1

Meeting - Rep to Patient Care

Project Management

  • Schedule for Conference calls
  • DMP - 2018
  • M&C - 2018
  • SWOT - 2018
  • Reaffirmation/Withdrawal of 5 year items
  • Forward Planning
  • Project Review
    • 3 year plan review
  • Action Item list review
  • Addition of another chair

Jean

Melva


AMQ2

Joint Meeting with FHIR-I - Pharmacy Hosting

Jean

Melva


PMQ3

Not Meeting



PMQ4

Not Meeting



  • No labels